Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPM3480392 injection PCA for postoperative moderate-to-severe pain
CTR20233389Phase 2Completed
- Sponsor
- Luye Pharma Group
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LPM3480392 in postoperative pain, breakthrough pain, sponsored by Luye Pharma Group. Started Oct 2023; status: completed.
02
Drugs
LPM3480392
03
Conditions
postoperative painbreakthrough pain
Beyond the preview
Go deeper on CTR20233389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233389.